• By ICR Secretariat
  • Posted Tuesday, November 29, 2022

With Sanofi as its marketing partner, Provention Bio grabs long-awaited FDA nod for diabetes drug

https://www.fiercepharma.com/pharma/provention-bio-wins-long-awaited-fda-approval-type-1-diabetes-drug

What a long, strange trip it’s been for teplizumab, a drug developed to combat juvenile diabetes—36 years to be exact.